Physician profile
John Wells
NPI 1174532469
$5,147.74
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,747 · 2020: $1,343 · 2021: $1,133 · 2022: $925.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $732.04 | 2019-2022 | |
| Amgen INC. | $668.86 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $406.43 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $332.67 | 2019-2022 | |
| Eisai INC. | $272.77 | 2019-2022 | |
| Rigel Pharmaceuticals, INC. | $239.13 | 2020-2022 | |
| Beigene USA, INC. | $232.65 | 2020-2022 | |
| Celgene Corporation | $213.26 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $200.70 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $188.08 | 2019-2022 | |
| Lilly USA, LLC | $184.56 | 2019-2021 | |
| Coherus Oncology, INC. | $163.16 | 2020-2021 | |
| Pfizer INC. | $153.00 | 2019-2022 | |
| Exelixis INC. | $148.00 | 2019-2022 | |
| Seagen INC. | $143.77 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $126.98 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.15 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $72.14 | 2022 | |
| Incyte Corporation | $70.79 | 2019-2022 | |
| Genentech USA, INC. | $62.63 | 2019-2022 | |
| Clovis Oncology, INC. | $59.88 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $46.52 | 2020 | |
| Cti Biopharma Corp. | $38.18 | 2022 | |
| Gilead Sciences, INC. | $38.18 | 2022 | |
| Dendreon Pharmaceuticals LLC | $34.42 | 2019-2022 | |
| G1 Therapeutics, INC. | $28.05 | 2022 | |
| Janssen Biotech, INC. | $23.37 | 2020-2022 | |
| Daiichi Sankyo INC. | $22.05 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $21.23 | 2022 | |
| Karyopharm Therapeutics INC. | $21.14 | 2022 | |
| Morphosys, US INC. | $17.67 | 2021 | |
| Array Biopharma INC | $16.64 | 2019 | |
| Emd Serono, INC. | $16.37 | 2022 | |
| Kyowa Kirin, INC. | $16.11 | 2022 | |
| Puma Biotechnology, INC. | $13.08 | 2019 | |
| Adc Therapeutics America, INC. | $12.08 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.